have recently shown that β-catenin inhibition shifts the colorectal tumor microenvironment into a T cell-inflamed phenotype through the up-regulation of T/NK cell-recruiting CXCR3 chemokines CXCL9/10/11 (28). The gene discussed is CXCL9; the disease is colorectal neoplasm.